Posted in | News | Business

BASF Completes Acquisition of Degussa's Construction Chemicals Business

The acquisition of Degussa AG’s construction chemicals business by BASF Aktiengesellschaft was completed on July 1. The purchase price for equity is just under €2.2 billion. As a result, the transaction value for BASF is €2.7 billion.

The acquisition of Degussa’s global construction chemicals activities includes production sites and sales centers in over 50 countries as well as a research and development center in Trostberg, Germany.

“Construction chemicals is an innovative business area with cyclically resilient margins that we will develop into a profitable growth sector in BASF’s portfolio,” said Dr. Andreas Kreimeyer, member of the Board of Executive Directors of BASF Aktiengesellschaft responsible for the Performance Products segment. “We will now work together to integrate Degussa’s operations quickly into our existing business. In doing so, we will rely in particular on the expertise and innovativeness of our new colleagues. Together with our own staff, our aim is to build the best team in construction chemicals.”

“BASF is a strong and reliable partner that is pursuing a long-term strategy with this acquisition. I am pleased to have the opportunity to develop this business further with my team and provide new solutions for our customers,” said Dr. Bernhard Hofmann, head of BASF’s Construction Chemicals division. Hofmann was a member of the Board of Management of Degussa AG until the end of April 2006 and was head of the Construction Chemicals division at Degussa from 2001 to 2003.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.